Eli Lilly Scraps Major Cholesterol-Inhibitor Drug; Shares Fall 7.7%
October 12, 2015 at 19:30 PM EDT
Eli Lilly announces the discontinuation of its drug evacetrapib used to treat patients with high levels of bad cholesterol
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.